Biolex [Added item on IPO cancellation.] Biolex has a production platform for protein drugs that uses transgenic plants. Here's a partial list of relevant posts: <a href='read_msg.asp?message_id=25179852'>#msg-25179852</a> Anti-CD20 (Rituxan FoB) program <a href='read_msg.asp?message_id=23627540'>#msg-23627540</a> Locteron (ifn-alpha) phase-2 data <a href='read_msg.asp?message_id=26487825'>#msg-26487825</a> IPO withdrawal <a href='read_msg.asp?message_id=21229000'>#msg-21229000</a> BLX-155 clot-buster program <a href='read_msg.asp?message_id=19450622'>#msg-19450622</a> Collaboration with Genmab <a href='read_msg.asp?message_id=15116312'>#msg-15116312</a> Homogeneity of glycosylation <a href='read_msg.asp?message_id=5919466'>#msg-5919466</a> ‘Plantibody’ patent